VNOV · VitaNova Life Sciences Corp · Executive Compensation
Market Cap
$11.51M
Shares
8.34M
Volume · Apr 20
2447
Avg daily vol (1 sessions)
2447
Named-executive compensation from the company's DEF 14A proxy statements — salary, bonus, stock and option awards, non-equity incentive, and the company-reported total per executive per fiscal year, exactly as disclosed in the Summary Compensation Table.
No Compensation Data
No Summary Compensation Table has been imported from this company's proxy statements yet.
Executive changes
| Person | Role | Change | Filed |
|---|---|---|---|
| Ruiming Zhou | director | Resigned | 2026-03-18 |
| Steve Niu | CFO | Appointed | 2024-01-12 |
| Qiuping Lu | CFO | Resigned | 2024-01-12 |
| Ruiming Zhou | Director | Appointed | 2023-09-14 |
| Qiuping Lu | Director | Appointed | 2023-09-14 |
| Qiuping Lu | Chief Financial Officer | Appointed | 2023-09-14 |
| Qiuping Lu | Chief Executive Officer | Appointed | 2023-09-14 |
| Xianchang Ma | Director | Terminated | 2023-09-14 |
| Xianchang Ma | Chief Financial Officer | Terminated | 2023-09-14 |
| Xianchang Ma | Chief Executive Officer | Terminated | 2023-09-14 |
| Xianchang Ma | Director | Appointed | 2023-06-15 |
| Xianchang Ma | Chief Financial Officer | Appointed | 2023-06-15 |
| Xianchang Ma | President | Appointed | 2023-06-15 |
| Xianchang Ma | Chief Executive Officer | Appointed | 2023-06-15 |
| Barry Sytner | Chief Financial Officer | Resigned | 2023-06-15 |
| Barry Sytner | Director | Resigned | 2023-06-15 |
| Barry Sytner | President | Resigned | 2023-06-15 |
| Barry Sytner | Chief Executive Officer | Resigned | 2023-06-15 |
Key facts
CIK
1699709